| Composition |
| Each tablet contains: |
| • | Nimesulide 100 mg |
| • | Serratiopeptidase 15 mg |
Features |
| • | A non-steroidal anti-inflammatory drug with selective activity on COX2 Contains nimesulide which has analgesic, anti-pyretic and anti-inflammatory properties |
| • | Also contains serratiopeptidase - a metalloprotease enzyme with proteolytic, fibrinolytic, mucolytic and anti-inflammatory properties |
Benefits |
| • | Nimesulide has a more profound inhibiting activity on pro-inflammatory prostaglandins and relatively less on physiological prostaglandins. It also inhibits a variety of other inflammatory mediators, such as PAF, TNF alpha, histamines, superoxide anions etc., Serratiopeptidase improves microcirculation and helps the anti-microbials to reach the site of infection faster. It also speeds up the resolution of haematoma |
| • | Highly effective in treating trauma, fractures and musculoskeletal injury |
| • | Also useful in post-operative conditions, gynaecological procedures and dental procedures |
|
 |
| Dosage |
| • | As directed by the Physician. (Please refer the detailed product literature for contraindications, special precautions, drug interactions, adverse effects and overdose) |
Packaging |
| • | Box containing 10 blisters of 10 tablets each |
|
